OxySure Therapeutics, Inc. 5/A
5/A · OxySure Therapeutics, Inc. · Filed Mar 7, 2016
Insider Transaction Report
Form 5/AAmended
JONES JEREMY M
Director
Transactions
- Other
Common stock
2016-02-15$0.18/sh+50,000$9,250→ 364,292 total(indirect: By Trust)
Holdings
- 314,292(indirect: By Trust)
Common stock
Footnotes (1)
- [F1]Acquired as an incentive for extending the due date of certain payment obligations by the Company.